NASDAQ · Medical - Healthcare Information Services

Progyny, Inc. (PGNY) Stock

$27.72 -0.40% NASDAQ: PGNY Healthcare

Valuation

MetricValue
Price$27.72
Market Cap$2.17B
P/E Ratio26.09
P/B Ratio4.36
P/S Ratio1.51
EPS (TTM)$0.65
52-Week High$33.07
52-Week Low$16.10
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE15.98%
ROA10.98%
ROCE23.57%
Gross Margin24.11%
Operating Margin7.46%
Net Margin6.00%
Debt/Equity0.06
Current Ratio2.73

Annual Financials (USD)

Metric20212022202320242025
Revenue$501.0M$787.0M$1.1B$1.2B$1.3B
Operating Profit$32.0M$23.0M$62.0M$67.0M$85.0M
Net Profit$66.0M$30.0M$62.0M$54.0M$59.0M
EPS$0.66$0.30$0.62$0.57$0.65
Op Margin6.5%3.0%5.7%5.8%6.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$358.0M$543.0M$757.0M$607.0M$742.0M
Total Liabilities$106.0M$166.0M$203.0M$185.0M$226.0M
Cash$91.0M$120.0M$97.0M$162.0M$112.0M
Borrowings$9.0M$8.0M$19.0M$19.0M$28.0M

Latest News

PGNY: Lowering target price to $35.00 Argus Research · Jul 22, 2026 Progyny COO Cummings Sells 3,437 Shares for $109,000 -- Here's What That Means for Investors Motley Fool · Jul 19, 2026 1 Cash-Producing Stock with Competitive Advantages and 2 Facing Challenges StockStory · Jul 17, 2026 Progyny (PGNY) Stock May Be 50% Undervalued On Fresh Analyst Upgrades Simply Wall St. · Jul 16, 2026 Does Rising Analyst Optimism On June Trends Reframe Progyny’s (PGNY) Employer-Demand Story? Simply Wall St. · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$26.0M$80.0M$189.0M$179.0M$210.0M
Investing Cash Flow$7.0M$-47.0M$-204.0M$190.0M$-177.0M
Financing Cash Flow$-18.0M$-12.0M$-17.0M$-312.0M$-101.0M
Net Cash Flow$21.0M$29.0M$-23.0M$65.0M$-48.0M
Free Cash Flow$24.0M$77.0M$185.0M$174.0M$192.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.46
EV / EBITDA14.61
FCF Yield10.99%
Quick Ratio2.14
Interest Coverage0.00
Return 1Y36.42%
Return 3Y-21.51%
Return 5Y-44.61%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $334.02 -1.88% 38.93 $4.91T 0.32%
MSFTMicrosoft Corporation $532.16 +1.83% 28.68 $3.95T 0.76%
GOOGLAlphabet Inc. $351.35 +0.88% 16.94 $4.25T 0.26%
AMZNAmazon.com, Inc. $259.66 +2.20% 19.82 $2.79T 0.00%
METAMeta Platforms, Inc. $721.12 +0.03% 27.93 $1.84T 0.28%

About Progyny, Inc.

Progyny, Inc. (PGNY) stock trades at $27.72 with a market capitalization of $2.17B. The stock is valued at a price-to-earnings (P/E) ratio of 26.09, price-to-book of 4.36, price-to-sales of 1.51. Over the past 52 weeks the stock has ranged between $16.10 and $33.07, and currently trades 16.2% below its 52-week high.

On profitability, Progyny, Inc. generates a return on equity (ROE) of 15.98%, above the typical market average, return on capital employed of 23.57%, an operating margin of 7.46%, a net profit margin of 6.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.40 -0.02% JNJ Johnson & Johnson $259.53 +1.19% ABBV AbbVie Inc. $275.22 +1.03% MRK Merck & Company, Inc. Common Stock (new) $144.97 +1.82% UNH UnitedHealth Group Incorporated Common Stock (DE) $374.45 +0.94% NVS Novartis AG $143.67 +0.39% AZN AstraZeneca PLC $159.80 +0.64% TMO Thermo Fisher Scientific Inc $656.26 +0.66% AMGN Amgen Inc. $410.76 +0.82% GILD Gilead Sciences, Inc. $149.60 +1.70% ABT Abbott Laboratories $99.62 +1.15% NVO Novo Nordisk A/S $38.39 +0.54%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides